Peter Johann
Amministratore Delegato presso Lumendi Ltd.
Provenienza dei contatti di primo grado di Peter Johann
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
NGN Capital LLC
 NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York.
15
| Private Company | Investment Managers | 15 |
| Public Company | Pharmaceuticals: Major | 13 | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.
9
| Subsidiary | Biotechnology | 9 |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.
9
| Subsidiary | Medical/Nursing Services | 9 |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
Vivaldi Biosciences, Inc.
 Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO.
6
| Holding Company | Drugstore Chains | 6 |
Vivaldi Biosciences AG
 Vivaldi Biosciences AG BiotechnologyHealth Technology Vivaldi Biosciences AG is a venture-backed company that focuses on research and development. It develops genetically engineered intranasal vaccines for epidemic and pandemic viral respiratory diseases. The company is headquartered in Vienna, Austria.
3
| Private Company | Biotechnology | 3 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Lumendi Ltd.
 Lumendi Ltd. Medical SpecialtiesHealth Technology Lumendi Ltd. develops medical devices for the treatment of gastrointestinal conditions. The private company is based in Maidenhead, UK. The British company was founded in 2014 by Peter Johann. Peter Johann has been the CEO since 2014.
2
| Private Company | Medical Specialties | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Peter Johann tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Consultant / Advisor Corporate Officer/Principal | |
| NEUROLOGIX, INC. | Internet Software/Services | Director/Board Member Director/Board Member | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| SERNOVA CORP. | Biotechnology | Director/Board Member Director/Board Member | |
BeneChill, Inc.
 BeneChill, Inc. Medical SpecialtiesHealth Technology BeneChill, Inc. develops non-invasive cooling technology for cerebral ischemia treatment. The company was founded by Michael L. Berman and Denise Barbut in 2004 is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Cerapedics, Inc.
 Cerapedics, Inc. Pharmaceuticals: MajorHealth Technology Cerapedics, Inc. engaged in the provision of developing and commercializing novel osteobiologic products. It offers i-FACTOR Bone Graft, an advanced biologic that supported with level I evidence, and provides benefit ratio. The company was founded by Andrew J. Tofe and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NEUROTROPE, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ZENITH CAPITAL CORP. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member | |
| EVOTEC SE | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Freiburg | College/University | Doctorate Degree Undergraduate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MEDIAN Kliniken GmbH
 MEDIAN Kliniken GmbH Hospital/Nursing ManagementHealth Services MEDIAN Kliniken GmbH engages in the operation of hospitals and rehabilitation centers. It provides medical services, which focus on the areas of neurology, cardiology, psychosomatics, and orthopedic rehabilitation. The firm also manages acute hospitals, resettlement facilities, specialist hospitals, and care facilities. The company was founded by Erich Marx and Axel Steinwarz in 1967 and is headquartered in Berlin, Germany. | Hospital/Nursing Management | Director/Board Member | |
| Babson College | College/University | Masters Business Admin Masters Business Admin | |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Graduate Degree Corporate Officer/Principal | |
| University of Manitoba | College/University | Undergraduate Degree Graduate Degree | |
| University of Maryland | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Calgary | College/University | Undergraduate Degree Corporate Officer/Principal President | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| Freie Universität Berlin | College/University | Undergraduate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Order of Canada
 Order of Canada Miscellaneous Commercial ServicesCommercial Services Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Founder Director/Board Member | |
Valtech Cardio Ltd.
 Valtech Cardio Ltd. Medical SpecialtiesHealth Technology Valtech Cardio Ltd. develops devices for mitral valve repair and replacement. It specializes in the development of devices for mitral and tricuspid valve repair and replacement. The firm also offers full in-house development, manufacturing and clinical research capabilities, and patent applications. The company was founded by Amir Gross and Yossi Gross in March 2005 and is headquartered in Or Yehuda, Israel. | Medical Specialties | Director/Board Member Director/Board Member | |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Medical/Nursing Services | Director/Board Member | |
| ISOFOL MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| TME PHARMA N.V. | Biotechnology | Director/Board Member Chairman Director/Board Member Founder Chairman Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
KaNDy Therapeutics Ltd.
 KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
Visum Pharma, Inc.
 Visum Pharma, Inc. Pharmaceuticals: MajorHealth Technology Visum Pharma, Inc. provides therapeutics for neurodegenerative diseases. The company is based in Stamford, CT. The CEO of the company is William J. Gedale. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Complement Therapeutics Ltd.
 Complement Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Complement Therapeutics Ltd. develops medicines that target the complement system. The British company was founded by Richard Unwin, Simon J. Clark, and Paul Bishop. The CEO is Rafiq Hasan. | Pharmaceuticals: Major | Director/Board Member | |
Pipra AG
 Pipra AG Packaged SoftwareTechnology Services Pipra AG is a company based in Zurich, Switzerland that was founded by John Klepper, Nayeli Schmutz, and Benjamin Dodsworth. The Swiss company is developing a cutting-edge AI-based pre-surgical tool to assess patients' risk of suffering from a postoperative delirium (POD) or a postoperative cognitive dysfunction (POCD). John Klepper has been the CEO since incorporation. | Packaged Software | Director/Board Member | |
CastleVax, Inc.
 CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre. | Biotechnology | Founder Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 25 |
| Germania | 10 |
| Canada | 7 |
| Svizzera | 4 |
| Svezia | 3 |
Settori
| Health Technology | 33 |
| Consumer Services | 13 |
| Technology Services | 3 |
| Health Services | 3 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 335 |
| Corporate Officer/Principal | 119 |
| Chairman | 88 |
| Chief Executive Officer | 54 |
| Independent Dir/Board Member | 50 |
Contatti più connessi
| Insiders | |
|---|---|
| Douglass Given | 35 |
| Eldon Smith | 29 |
| Arthur Higgins | 29 |
| Joseph deBethizy | 29 |
| Erich Hunziker | 28 |
| Hubert Birner | 27 |
| Denis Lucquin | 26 |
| Kenneth S. Abramowitz | 24 |
| Olivier Litzka | 21 |
| Robert Bider | 21 |
| William A. Cochrane | 21 |
| William Gedale | 20 |
| Stella M. Thompson | 18 |
| Alan Henry Raffensperger | 17 |
| J. Carroll | 17 |
- Borsa valori
- Insiders
- Peter Johann
- Connessioni Società
